Dengue vaccine is effective and safe, reveals first global meta-analysis

Dengue_Virus_Particles_(53231044882) (1)

Source: CDC/NIAID

The study, conducted by cross-referencing data from 19 scientific studies, involving over 20,000 individuals, shows an efficacy rate of over 50% in reducing disease cases, with lasting effects and a high safety profile.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE